Skip to Main Content

Paper Details

Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Proc Natl Acad Sci U S A
29
2021
AAVP, CMV promoter, COVID, COVID-19, S, S protein gene, S protein-specific antibody, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike, adeno, coronavirus disease, human, humans, major capsid protein, mice, minor capsid protein pIII, pVIII, tissue, transgene
Author NameAffiliation
Fernanda I StaquiciniRutgers Cancer Institute of New Jersey
Fernanda I StaquiciniRutgers New Jersey Medical School
Richard L SidmanHarvard Medical School
Maria Laura GennaroPublic Health Research Institute, Rutgers New Jersey Medical School
Maria Laura GennaroPublic Health Research Institute, Rutgers New Jersey Medical School
Stephen K BurleyRutgers Cancer Institute of New Jersey
Stephen K BurleyRCSB Protein Data Bank and Institute for Quantitative Biomedicine, The State University of New Jersey
Stephen K BurleyThe State University of New Jersey
Stephen K BurleySan Diego Supercomputer Center and Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego
Wadih ArapRutgers Cancer Institute of New Jersey
Wadih ArapRutgers New Jersey Medical School
Renata PasqualiniRutgers Cancer Institute of New Jersey
Renata PasqualiniRutgers New Jersey Medical School
  • 1 - 13

Datasets

Release 1.2